WANG Z, DEWITT J C, HIGGINS C P, et al. A Never-ending story of per-and polyfluoroalkyl substances (PFASs)?[J]. Environmental Science & Technology, 2017,51(5):2508-2518.
NELSON J W, HATCH E E, WEBSTER T F. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population[J]. Environ Health Perspect, 2010,118(2):197-202.
JONES P D, HU W, DE COEN W, et al. Binding of perfluorinated fatty acids to serum proteins[J]. Environmental Toxicology and Chemistry, 2003,22(11):2639-2649.
KARÁSKOVÁ P, VENIER M, MELYMUK L, et al. Perfluorinated alkyl substances (PFASs) in household dust in Central Europe and North America[J]. Environment International, 2016,94:315-324.
ZHANG T, WU Q, SUN H W, et al. Perfluorinated compounds in whole blood samples from infants, children, and adults in China[J]. Environmental Science & Technology, 2010,44(11):4341-4347.
ZHENG F, SHENG N, ZHANG H, et al. Perfluorooctanoic acid exposure disturbs glucose metabolism in mouse liver[J]. Toxicology and Applied Pharmacology, 2017,335:41-48.
MANERA M, GIARI L, VINCENZI F, et al. Texture analysis in liver of common carp (Cyprinus carpio) sub-chronically exposed to perfluorooctanoic acid[J]. Ecological Indicators, 2017,81:54-64.
LAU C, ANITOLE K, HODES C, et al. Perfluoroalkyl acids:A review of monitoring and toxicological findings[J]. Toxicol Sci, 2007,99(2):366-394.
ZHANG T, SUN H, LIN Y, et al. Perfluorinated compounds in human blood, water, edible freshwater fish, and seafood in china:Daily intake and regional differences in human exposures[J]. Journal of Agricultural and Food Chemistry, 2011,59(20):11168-11176.
ZHANG T, SUN H, QIN X, et al. PFOS and PFOA in paired urine and blood from general adults and pregnant women:Assessment of urinary elimination[J]. Environmental Science and Pollution Research International, 2015,22(7):5572-5579.
ZHANG Y, JIANG W, FANG S, et al. Perfluoroalkyl acids and the isomers of perfluorooctanesulfonate and perfluorooctanoate in the sera of 50 new couples in Tianjin, China[J]. Environment International, 2014,68:185-191.
VERREAULT J, HOUDE M, GABRIELSEN G W, et al. Perfluorinated alkyl substances in plasma, liver, brain, and eggs of glaucous gulls (larus hyperboreus) from the norwegian arctic[J]. Environmental Science & Technology, 2005,39(19):7439-7445.
HANSEN K J, CLEMEN L A, ELLEFSON M E, et al. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices[J]. Environmental Science & Technology, 2001,35(4):766-770.
OLSEN G W, HANSEN K J, STEVENSON L A, et al. Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals[J]. Environmental Science & Technology, 2003,37(5):888-891.
MAESTRI L, NEGRI S, FERRARI M, et al. Determination of perfluorooctanoic acid and perfluorooctanesulfonate in human tissues by liquid chromatography/single quadrupole mass spectrometry[J]. Rapid Communications in Mass Spectrometry, 2006,20(18):2728-2734.
KÄRRMAN A, DOMINGO J L, LLEBARIA X, et al. Biomonitoring perfluorinated compounds in Catalonia, Spain:Concentrations and trends in human liver and milk samples[J]. Environmental Science and Pollution Research, 2010,17(3):750-758.
YEUNG L W Y, GURUGE K S, TANIYASU S, et al. Profiles of perfluoroalkyl substances in the liver and serum of patients with liver cancer and cirrhosis in Australia[J]. Ecotoxicology and Environmental Safety, 2013,96:139-146.
MAMSEN L S, JÖNSSON B A G, LINDH C H, et al. Concentration of perfluorinated compounds and cotinine in human foetal organs, placenta, and maternal plasma[J]. Science of the Total Environment, 2017,596-597:97-105.
MAMSEN L S, BJÖRVANG R D, MUCS D, et al. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies[J]. Environment International, 2019,124:482-492.
LI L, ZHAI Z, LIU J, et al. Estimating industrial and domestic environmental releases of perfluorooctanoic acid and its salts in China from 2004 to 2012[J]. Chemosphere, 2015,129:100-109.
OLSEN G W, MAIR D C, LANGE C C, et al. Per-and polyfluoroalkyl substances (PFAS) in American Red Cross adult blood donors, 2000-2015[J]. Environmental Research, 2017,157:87-95.
XIE S, WANG T, LIU S, et al. Industrial source identification and emission estimation of perfluorooctane sulfonate in China[J]. Environment International, 2013,52:1-8.
JIN Y, SAITO N, HARADA K H, et al. Historical trends in human serum levels of perfluorooctanoate and perfluorooctane sulfonate in Shenyang, China[J]. The Tohoku Journal of Experimental Medicine, 2007,212(1):63-70.
SUNDERLAND E M, HU X C, DASSUNCAO C, et al. A review of the pathways of human exposure to poly-and perfluoroalkyl substances (PFASs) and present understanding of health effects[J]. Journal of Exposure Science & Environmental Epidemiology, 2019,29(2):131-147.
NAKAYAMA K, IWATA H, TAO L, et al. Potential effects of perfluorinated compounds in common cormorants from Lake Biwa, Japan:An implication from the hepatic gene expression profiles by microarray[J]. Environmental Toxicology and Chemistry, 2008,27(11):2378.
GURUGE K S, MANAGE P M, YAMANAKA N, et al. Species-specific concentrations of perfluoroalkyl contaminants in farm and pet animals in Japan[J]. Chemosphere, 2008,73(1):S210-S215.
ISHIBASHI H, IWATA H, KIM E, et al. Contamination and effects of perfluorochemicals in baikal seal (pusa sibirica).1. Residue level, tissue distribution, and temporal trend[J]. Environmental Science & Technology, 2008,42(7):2295-2301.
KANNAN K, CORSOLINI S, FALANDYSZ J, et al. Perfluorooctanesulfonate and related fluorinated hydrocarbons in marine mammals, fishes, and birds from coasts of the baltic and the mediterranean seas[J]. Environmental Science & Technology, 2002,36(15):3210-3216.
CHO C R, LAM N H, CHO B M, et al. Concentration and correlations of perfluoroalkyl substances in whole blood among subjects from three different geographical areas in Korea[J]. Science of The Total Environment, 2015,512-513:397-405.
FU Y, WANG T, WANG P, et al. Effects of age, gender and region on serum concentrations of perfluorinated compounds in general population of Henan, China[J]. Chemosphere, 2014,110:104-110.
HSU J, HSU J, HO H, et al. Background levels of persistent organic pollutants in humans from taiwan:Perfluorooctane sulfonate and perfluorooctanoic acid[J]. Chemosphere, 2013,93(3):532-537.
WAN H T, LEUNG P Y, ZHAO Y G, et al. Blood plasma concentrations of endocrine disrupting chemicals in Hong Kong populations[J]. Journal of Hazardous Materials, 2013,261:763-769.
FROMME H, MIDASCH O, TWARDELLA D, et al. Occurrence of perfluorinated substances in an adult German population in southern Bavaria[J]. International Archives of Occupational and Environmental Health, 2007,80(4):313-319.
KÄRRMAN A, MUELLER J F, van BAVEL B, et al. Levels of 12 perfluorinated chemicals in pooled australian serum, collected 2002-2003, in Relation to Age, Gender, and Region[J]. Environmental Science & Technology, 2006,40(12):3742-3748.
CALAFAT A M, KUKLENYIK Z, REIDY J A, et al. Serum concentrations of 11 polyfluoroalkyl compounds in the U.S. Population:Data from the National Health and Nutrition Examination Survey (NHANES) 1999-2000[J]. Environmental Science & Technology, 2007,41(7):2237-2242.
WONG F, MACLEOD M, MUELLER J F, et al. Enhanced elimination of perfluorooctane sulfonic acid by menstruating women:Evidence from population-based pharmacokinetic modeling[J]. Environmental Science & Technology, 2014,48(15):8807-8814.
FROMME H, MOSCH C, MOROVITZ M, et al. Pre-and postnatal exposure to perfluorinated compounds (PFCs)[J]. Environmental Science & Technology, 2010,44(18):7123-7129.
TAO L, MA J, KUNISUE T, et al. Perfluorinated compounds in human breast milk from several Asian countries, and in infant formula and dairy milk from the United States[J]. Environmental Science & Technology, 2008,42(22):8597-8602.
HARADA K, INOUE K, MORIKAWA A, et al. Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion[J]. Environmental Research, 2005,99(2):253-261.
HAUG L S, THOMSEN C, BECHER G. Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples[J]. Environmental Science & Technology, 2009,43(6):2131-2136.
KLEPEIS N E, NELSON W C, OTT W R, et al. The National Human Activity Pattern Survey (NHAPS):A resource for assessing exposure to environmental pollutants[J]. J Expo Anal Environ Epidemiol, 2001,11(3):231-252.
PAN Y, SHI Y, WANG J, et al. Concentrations of perfluorinated compounds in human blood from twelve cities in China[J]. Environmental Toxicology and Chemistry, 2010,29(12):2695-2701.
KANNAN K, CORSOLINI S, FALANDYSZ J, et al. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries[J]. Environmental Science & Technology, 2004,38(17):4489-4495.
YEUNG L W Y, SO M K, JIANG G, et al. Perfluorooctanesulfonate and related fluorochemicals in human blood samples from China[J]. Environmental Science & Technology, 2006,40(3):715-720.
JAIN R B, Ducatman A. Selective associations of recent low concentrations of perfluoroalkyl substances with liver function biomarkers:NHANES 2011-2014 Data on US Adults Aged ≥ 20 Years[J]. Journal of Occupational and Environmental Medicine, 2019, 61(4):293-302.
DARROW L A, GROTH A C, WINQUIST A, et al. Modeled perfluorooctanoic acid (PFOA) exposure and liver function in a Mid-Ohio Valley Community[J]. Environmental Health Perspectives, 2016,124(8):1227-1233.
GALLO V, LEONARDI G, GENSER B, et al. Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA Exposure[J]. Environmental Health Perspectives, 2012,120(5):655-660.
BASSLER J, DUCATMAN A, ELLIOTT M, et al. Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines[J]. Environmental Pollution, 2019,247:1055-1063.
XIE Y, YANG Q, NELSON B D, et al. The relationship between liver peroxisome proliferation and adipose tissue atrophy induced by peroxisome proliferator exposure and withdrawal in mice[J]. Biochemical Pharmacology, 2003,66(5):749-756.
PHILIPPE G, ELISABETH WREFORD A, ESBEN B, et al. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds[J]. Journal of the American Medical Association, 2012,307(4):391-397.
WANG J, ZENG X, BLOOM M S, et al. Renal function and isomers of perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS):Isomers of C8 Health Project in China[J]. Chemosphere, 2019,218:1042-1049.
SHANKAR A, XIAO J, DUCATMAN A. Perfluoroalkyl chemicals and chronic kidney disease in US Adults[J]. American Journal of Epidemiology, 2011,174(8):893-900.
TIAN Y, ZENG X, BLOOM M S, et al. Isomers of perfluoroalkyl substances and overweight status among Chinese by sex status:Isomers of C8 Health Project in China[J]. Environment International, 2019,124:130-138.